PREVALENCE OF GENITAL MYCOPLASMA INFECTION AND ASSOCIATED FACTORS IN WOMEN WITH PRIMARY INFERTILITY
Main Article Content
Abstract
Objectives: To investigate the prevalence of genital Mycoplasma infection and associated factors among women with primary infertility.
Methods: A cross-sectional study was conducted on 78 women diagnosed with primary infertility at the Center for Reproductive Endocrinology and Infertility, Hue University of Medicine and Pharmacy Hospital. Participants underwent testing for sexually transmitted pathogens, including genital Mycoplasma.
Results: The prevalence of genital Mycoplasma infection in women with primary infertility was 41% (95% CI: 29.9-52.2%), of which Ureaplasma parvum infection (32.1%), Ureaplasma urelyticum (3.8%), co-infection with Ureaplasma parvum and Ureaplasma urelyticum (5.1%). No cases of Mycoplasma hominis or Mycoplasma genitalium infection were reported. There were no significant associations between genital mycoplasma infection and demographic or clinical characteristics, including age, occupation, educational level, medical history, menstrual characteristics, and sexual behaviors. However, women with a history of infertility treatment had a higher risk of genital Mycoplasma infection compared with those without such history (ORadj = 5.67; 95% CI: 1.50-21.45; p = 0.010), after adjusting for age, education and occupation.
Conclusion: Genital Mycoplasma infection is a noteworthy concern among women with primary infertility, with Ureaplasma parvum being the most frequently detected pathogen. Screening and management of genital infections in women with primary infertility should pay particular attention to those with a history of infertility treatment.
Article Details
Keywords
Genital Mycoplasma, primary infertility, women, STDs.
References
[2] Moghaddam H.E, Kheirkhah B et al. A comparison between the molecular identity of Mycoplasma hominis in urine samples of patients with urinary tract infections and similar strains available in GenBank. J Babol Univ Med Sci, 2015, 17 (10): 67-73.
[3] Moridi K, Hemmaty M et al. Epidemiology of genital infections caused by Mycoplasma hominis, M.genitalium and Ureaplasma urealyticum in Iran: a systematic review and meta-analysis study (2000-2019). BMC Public Health, 2020, 20 (1): 1020. doi: 10.1186/s12889-020-08962-5.
[4] Seifoleslami M, Safari A et al. Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in high vaginal swab samples of infertile females. Iran Red Crescent Med J. 2015; 17 (12): 0-4. doi: 10.5812/ircmj.16823.
[5] Ghadiri A, Ahmadi K et al. Investigating Chlamydia trachomatis and genital Mycoplasma prevalence and apoptosis markers in infertile and fertile couples. Jundishapur J Microbiol, 2019, 12 (1): 1-7
[6] Raj J.S, Rawre J et al. Mycoplasma genitalium: a new superbug. Indian J Sex Transm Dis AIDS, 2022, 43 (1): 1-12. doi: 10.4103/ijstd.ijstd_103_20.
[7] Leli C, Mencacci A et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect, 2018, 51 (2): 220-225. doi: 10.1016/j.jmii.2017.05.004.
[8] Sadeqi S, Nikkhahi F et al. Development of multiplex real-time quantitative PCR for simultaneous detection of Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum, and Mycoplasma genitalium in infertile women. Indian J Med Microbiol, 2022, 40 (2): 231-234. doi: 10.1016/j.ijmmb.2022.01.011.
[9] Karim S, Bouchikhi C et al. Detection of Ureaplasma biovars and subtyping of Ureaplasma parvum among women referring to a university hospital in Morocco. Infect Dis Obstet Gynecol, 2020: 7286820. doi: 10.1155/2020/7286820.
[10] Tantengco O.A.G, de Castro Silva M et al. The role of genital mycoplasma infection in female infertility: a systematic review and meta-analysis. Am J Reprod Immunol, 2021, 85 (6): e13390. doi: 10.1111/aji.13390.